Cargando…

DDX3X Biomarker Correlates with Poor Survival in Human Gliomas

Primary high-grade gliomas possess invasive growth and lead to unfavorable survival outcome. The investigation of biomarkers for prediction of survival outcome in patients with gliomas is important for clinical assessment. The DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked (DDX3X) controls tumor mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hueng, Dueng-Yuan, Tsai, Wen-Chiuan, Chiou, Hsin-Ying Clair, Feng, Shao-Wei, Lin, Chin, Li, Yao-Feng, Huang, Li-Chun, Lin, Ming-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519914/ https://www.ncbi.nlm.nih.gov/pubmed/26184164 http://dx.doi.org/10.3390/ijms160715578

Ejemplares similares

Overexpression of TELO2 decreases survival in human high-grade gliomas
por: Feng, Shao-Wei, et al.
Publicado: (2016)

Clinical Significance and Systematic Expression Analysis of the Thyroid Receptor Interacting Protein 13 (TRIP13) as Human Gliomas Biomarker
por: Chen, Ssu-Han, et al.
Publicado: (2021)

Shugoshin 2 is a biomarker for pathological grading and survival prediction in patients with gliomas
por: Kao, Ying, et al.
Publicado: (2021)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2016)

Midkine expression in high grade gliomas: Correlation of this novel marker with proliferation and survival in human gliomas
por: Cheng, Yen-Po, et al.
Publicado: (2014)

Proteolipid Protein 2 Overexpression Indicates Aggressive Tumor Behavior and Adverse Prognosis in Human Gliomas
por: Chen, Yi-Hsuan, et al.
Publicado: (2018)

ARID4B Knockdown Suppresses PI3K/AKT Signaling and Induces Apoptosis in Human Glioma Cells
por: Luo, Siou-Min, et al.
Publicado: (2021)

Ancient ubiquitous protein 1 (AUP1) is a prognostic biomarker connected with TP53 mutation and the inflamed microenvironments in glioma
por: Chang, Pei-Chi, et al.
Publicado: (2023)

Antiproliferative and apoptotic effects of telmisartan in human glioma cells
por: Chang, Yung-Lung, et al.
Publicado: (2023)

Interstitial Control-Released Polymer Carrying a Targeting Small-Molecule Drug Reduces PD-L1 and MGMT Expression in Recurrent High-Grade Gliomas with TMZ Resistance
por: Liu, Ching-Ann, et al.
Publicado: (2022)

EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
por: Tsai, Wen-Chiuan, et al.
Publicado: (2013)

Decoding the prognostic significance of integrator complex subunit 9 (INTS9) in glioma: links to TP53 mutations, E2F signaling, and inflammatory microenvironments
por: Lin, Yu-Chieh, et al.
Publicado: (2023)

CKAP2L Knockdown Exerts Antitumor Effects by Increasing miR-4496 in Glioblastoma Cell Lines
por: Li, Yao-Feng, et al.
Publicado: (2020)

Valproic acid promotes radiosensitization in meningioma stem-like cells
por: Chiou, Hsin-Ying Clair, et al.
Publicado: (2015)

Osteopontin regulates human glioma cell invasiveness and tumor growth in mice
por: Jan, Hsun-Jin, et al.
Publicado: (2010)

DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker
por: Zhang, Jingwen, et al.
Publicado: (2021)

The Anti-Cancer Effect of Four Curcumin Analogues on Human Glioma Cells
por: Luo, Siou-Min, et al.
Publicado: (2021)

DDX3X and DDX3Y are redundant in protein synthesis
por: Venkataramanan, Srivats, et al.
Publicado: (2021)

The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas
por: Cheng, Chiao-Pei, et al.
Publicado: (2016)

DDX3X regulates cell survival and cell cycle during mouse early embryonic development
por: Li, Qian, et al.
Publicado: (2014)

DDX10 and BYSL as the potential targets of chondrosarcoma and glioma
por: Quan, Xuemin, et al.
Publicado: (2021)

Gold nanoparticles as multimodality imaging agents for brain gliomas
por: Lai, Sheng-Feng, et al.
Publicado: (2015)

Integrative Bioinformatics Analysis Identifies DDX60 as a Potential Biomarker for Systemic Lupus Erythematosus
por: Chen, Wu, et al.
Publicado: (2023)

Glioblastoma Primary Cells Retain the Most Copy Number Alterations That Predict Poor Survival in Glioma Patients
por: Chen, Chia-Hua, et al.
Publicado: (2021)

DDX3X: structure, physiologic functions and cancer
por: Mo, Jie, et al.
Publicado: (2021)

Hybrid Strategy of Two-Level Cervical Artificial Disc and Intervertebral Cage: Biomechanical Effects on Tissues and Implants
por: Chung, Tzu-Tsao, et al.
Publicado: (2015)

DDX59-AS1 is a prognostic biomarker and correlated with immune infiltrates in OSCC
por: Sun, Yang, et al.
Publicado: (2022)

Exploring the Mechanism of Adjuvant Treatment of Glioblastoma Using Temozolomide and Metformin
por: Feng, Shao-Wei, et al.
Publicado: (2022)

Potential of Neural Stem Cell-Based Therapy for Parkinson's Disease
por: Chou, Chung-Hsing, et al.
Publicado: (2015)

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer
por: Abdel-Fatah, T M A, et al.
Publicado: (2014)

IKBIP is a novel EMT-related biomarker and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
por: Xu, Kun, et al.
Publicado: (2022)

Overexpression of DDX49 in prostate cancer is associated with poor prognosis
por: Tao, Junyue, et al.
Publicado: (2023)

An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells
por: Chiu, Wei-Hsin, et al.
Publicado: (2015)

PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma
por: Li, Haoyu, et al.
Publicado: (2021)

DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective
por: Secchi, Massimiliano, et al.
Publicado: (2022)

Corrigendum: DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression
por: Xu, Kun, et al.
Publicado: (2023)

Analysis of volumetric response of pituitary adenomas receiving adjuvant CyberKnife stereotactic radiosurgery with the application of an exponential fitting model
por: Yu, Yi-Lin, et al.
Publicado: (2017)

BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u4bfhgst94jlluthb0bfjvfnf0